Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the second quarter ended June 28, 2025.

Vizient announced today the expansion of the Vizient Reserve Program to include IV fluids through a strategic partnership with Baxter.